187 related articles for article (PubMed ID: 24847761)
1. RSPO fusion transcripts in colorectal cancer in Japanese population.
Shinmura K; Kahyo T; Kato H; Igarashi H; Matsuura S; Nakamura S; Kurachi K; Nakamura T; Ogawa H; Funai K; Tanahashi M; Niwa H; Sugimura H
Mol Biol Rep; 2014 Aug; 41(8):5375-84. PubMed ID: 24847761
[TBL] [Abstract][Full Text] [Related]
2. EIF3E-RSPO2 and PIEZO1-RSPO2 fusions in colorectal traditional serrated adenoma.
Hashimoto T; Ogawa R; Yoshida H; Taniguchi H; Kojima M; Saito Y; Sekine S
Histopathology; 2019 Aug; 75(2):266-273. PubMed ID: 30916365
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
Hashimoto T; Takayanagi D; Yonemaru J; Naka T; Nagashima K; Yatabe Y; Shida D; Hamamoto R; Kleeman SO; Leedham SJ; Maughan T; Takashima A; Shiraishi K; Sekine S
Br J Cancer; 2022 Oct; 127(6):1043-1050. PubMed ID: 35715628
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas.
Sekine S; Ogawa R; Hashimoto T; Motohiro K; Yoshida H; Taniguchi H; Saito Y; Yasuhiro O; Ochiai A; Hiraoka N
Histopathology; 2017 Oct; 71(4):601-609. PubMed ID: 28543708
[TBL] [Abstract][Full Text] [Related]
5. CD44-SLC1A2 fusion transcripts in primary colorectal cancer.
Shinmura K; Kato H; Igarashi H; Inoue Y; Nakamura S; Du C; Kurachi K; Nakamura T; Ogawa H; Tanahashi M; Niwa H; Sugimura H
Pathol Oncol Res; 2015 Jul; 21(3):759-64. PubMed ID: 25576211
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical significance of 491 known fusion genes in a large cohort of Japanese patients with colorectal cancer.
Nanishi K; Hino H; Hatakeyama K; Shiomi A; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
Int J Clin Oncol; 2023 Jun; 28(6):785-793. PubMed ID: 37022622
[TBL] [Abstract][Full Text] [Related]
7. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers.
Conboy CB; Vélez-Reyes GL; Rathe SK; Abrahante JE; Temiz NA; Burns MB; Harris RS; Starr TK; Largaespada DA
DNA Cell Biol; 2021 Jan; 40(1):70-79. PubMed ID: 33320737
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of R-spondins in triple-negative and metaplastic breast cancers.
Coussy F; Lallemand F; Vacher S; Schnitzler A; Chemlali W; Caly M; Nicolas A; Richon S; Meseure D; El Botty R; De-Plater L; Fuhrmann L; Dubois T; Roman-Roman S; Dangles-Marie V; Marangoni E; Bièche I
Br J Cancer; 2017 Jun; 116(12):1595-1603. PubMed ID: 28472820
[TBL] [Abstract][Full Text] [Related]
9. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness.
Gong X; Yi J; Carmon KS; Crumbley CA; Xiong W; Thomas A; Fan X; Guo S; An Z; Chang JT; Liu QJ
Oncogene; 2015 Sep; 34(36):4692-701. PubMed ID: 25531322
[TBL] [Abstract][Full Text] [Related]
10. Recurrent R-spondin fusions in colon cancer.
Seshagiri S; Stawiski EW; Durinck S; Modrusan Z; Storm EE; Conboy CB; Chaudhuri S; Guan Y; Janakiraman V; Jaiswal BS; Guillory J; Ha C; Dijkgraaf GJ; Stinson J; Gnad F; Huntley MA; Degenhardt JD; Haverty PM; Bourgon R; Wang W; Koeppen H; Gentleman R; Starr TK; Zhang Z; Largaespada DA; Wu TD; de Sauvage FJ
Nature; 2012 Aug; 488(7413):660-4. PubMed ID: 22895193
[TBL] [Abstract][Full Text] [Related]
11. The role of R-spondin proteins in cancer biology.
Ter Steege EJ; Bakker ERM
Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
[TBL] [Abstract][Full Text] [Related]
12. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
[TBL] [Abstract][Full Text] [Related]
13. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
[TBL] [Abstract][Full Text] [Related]
14. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
Han T; Schatoff EM; Murphy C; Zafra MP; Wilkinson JE; Elemento O; Dow LE
Nat Commun; 2017 Jul; 8():15945. PubMed ID: 28695896
[TBL] [Abstract][Full Text] [Related]
15. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
[TBL] [Abstract][Full Text] [Related]
16. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
Wu C; Qiu S; Lu L; Zou J; Li WF; Wang O; Zhao H; Wang H; Tang J; Chen L; Xu T; Sun Z; Liao W; Luo G; Lu X
Nat Commun; 2014; 5():3149. PubMed ID: 24476626
[TBL] [Abstract][Full Text] [Related]
17. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
[TBL] [Abstract][Full Text] [Related]
18. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C
DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838
[TBL] [Abstract][Full Text] [Related]
19. Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
Picco G; Petti C; Centonze A; Torchiaro E; Crisafulli G; Novara L; Acquaviva A; Bardelli A; Medico E
EMBO Mol Med; 2017 Mar; 9(3):293-303. PubMed ID: 28100566
[TBL] [Abstract][Full Text] [Related]
20. Investigation of fusion gene expression in HCT116 cells.
Zhang Y; Ren J; Fang M; Wang X
Oncol Lett; 2017 Dec; 14(6):6962-6968. PubMed ID: 29181107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
